Tengion, Inc., a company developing ways create autologous new organs and tissues, has announced that it has implanted its Neo-Urinary Conduit in the first patient as part of a phase 1 clinical trial.
American Medical Systems (AMS) has launched the MoXy Liquid Cooled Fiber for laser treatment of benign prostatic hyperplasia (BPH).
Bristol-Myers Squibb of Princeton, N.J., has received FDA approval to market Baraclude (entecavir) as a treatment for chronic hepatitis B (CHB) patients with evidence of decompensated liver disease.
Pradaxa (dabigatran etexilate) capsules have received FDA approval for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).
The FDA has ordered a halt to the marketing of unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the treatment of familial Mediterranean fever.
Treating localized prostate cancer (PCa) with high-intensity focused ultrasound (HIFU) achieves disease-free survival rates similar to those expected with conformal external beam radiation therapy (EBRT), French researchers concluded.
Magnetic resonance imaging (MRI) may be superior to computed tomography for radiographic surveillance following laparoscopic renal cryoablation of renal masses, researchers reported at the World Congress of Endourology in Chicago.
Researchers have identified independent factors associated with early recovery of urinary continence after robot-assisted radical prostatectomy (RARP). These factors include lower preoperative PSA values, higher Sexual Health Inventory for Men (SHIM) score, and shorter operative time.
Nephrologists will be largely unaffected by the new rule, but small dialysis centers could be hit hard financially
Unlike Roux-en-Y gastric bypass (RYGB) procedures, restrictive bariatric surgery does not appear to be associated with an increased risk for kidney stones, a study found.
